Veradigm | MDRX - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Alcidion AUD 1.09M 184K 2025-12
Ambu A/S DKK 630M 37M 2026-09
Cardinal Health USD 1.6B 30M 2026-09
Centene USD 3.24B 132M 2026-09
Charles River Laboratories USD 140.59M 88.31M 2026-09
Cigna USD 3.61B 142M 2026-09
Coloplast 2.64B 52M 2025-12
Convatec Group USD 420.3M 210.35M 2024-12
Diasorin EUR 91.47M 35.47M 2026-06
Elevance Health USD 10.91B 309M 2025-12
General Electric Aerospace USD 1.09B 40M 2026-09
Gulf Medical Proj AED 806K 109K 2026-03
Humana USD 3.36B 614M 2025-03
IQVIA Holdings USD 569M 5M 2026-09
Laboratory Of America USD 611.4M 34.2M 2026-09
Max Healthcare Institute Limited 5.64B 407M 2026-09
Maximus USD 167.19M 6.29M 2026-06
McKesson USD 2.27B 5M 2026-09
Med Life RON 26.47M 3.41M 2026-03
Molina Healthcare USD 1.21B 19M 2026-09
Omnicell USD 100.54M 354K 2026-09
Oriola-kd EUR 13M 3.1M 2025-09
Owens Minor USD 258.98M 7.5M 2025-12
Quest Diagnostics USD 523M 6M 2026-09
Rede D'or Sao Luiz BRL 27.72M 117.93M 2026-06
Siemens Healthineers EUR 1.08B 68M 2026-09
Sonova Holding CHF 880.2M 300K 2025-06
UnitedHealth USD 15.22B 1.44B 2025-09
Veeva Systems USD 138.88M 12.4M 2026-06
Veradigm USD 27.28M 5.24M 2022-12
Xerox USD 368M 10M 2025-06